Sowell Financial Services’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-538
Closed -$42K 2108
2021
Q1
$42K Buy
538
+232
+76% +$18.1K ﹤0.01% 1729
2020
Q4
$22K Hold
306
﹤0.01% 1705
2020
Q3
$20K Hold
306
﹤0.01% 1565
2020
Q2
$20K Hold
306
﹤0.01% 1465
2020
Q1
$17K Hold
306
﹤0.01% 1442
2019
Q4
$20K Sell
306
-4,741
-94% -$288K ﹤0.01% 1440
2019
Q3
$286K Buy
+5,047
New +$290K 0.02% 551
2019
Q1
$387K Hold
5,944
0.04% 397
2018
Q4
$371K Buy
+5,944
New +$401K 0.05% 337

Other funds holding PJP

Sowell Financial Services's PJP Position: Q2 2021 in Review

Sowell Financial Services sold out of Invesco Pharmaceuticals ETF (PJP) in Q2 2021, closing a stake of 538 shares — an estimated $42K sold.

Sowell Financial Services first reported a position in PJP in Q4 2018 and held it in 9 quarters. The position peaked at $387K in Q1 2019. 90 funds tracked by Wall St. Rank hold PJP as of Q2 2021.

  • Sowell Financial Services reported no remaining Invesco Pharmaceuticals ETF position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 538 Invesco Pharmaceuticals ETF shares in Q2 2021, an estimated $42K.
  • Sowell Financial Services first reported a position in Invesco Pharmaceuticals ETF in Q4 2018 and held it in 9 quarters.
  • Sowell Financial Services's Invesco Pharmaceuticals ETF position peaked at $387K in Q1 2019.
  • 90 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.